BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32042082)

  • 1. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH).
    Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
    Leukemia; 2020 Aug; 34(8):2262-2264. PubMed ID: 32042082
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for cytogenomic analysis of hematologic malignancies: comments from the Francophone Group of Hematological Cytogenetics (GFCH).
    Nguyen-Khac F; Bidet A; Veronese L; Daudignon A; Penther D; Troadec MB; Lefebvre C; Lafage-Pochitaloff M
    Leukemia; 2020 Jun; 34(6):1711-1713. PubMed ID: 31862958
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
    Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).
    Nguyen-Khac F; Bidet A; Daudignon A; Lafage-Pochitaloff M; Ameye G; Bilhou-Nabéra C; Chapiro E; Collonge-Rame MA; Cuccuini W; Douet-Guilbert N; Eclache V; Luquet I; Michaux L; Nadal N; Penther D; Quilichini B; Terre C; Lefebvre C; Troadec MB; Véronèse L
    Leukemia; 2022 Jun; 36(6):1451-1466. PubMed ID: 35430613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
    Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
    Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Tueur G; Quessada J; De Bie J; Cuccuini W; Toujani S; Lefebvre C; Luquet I; Michaux L; Lafage-Pochitaloff M
    Curr Res Transl Med; 2023; 71(4):103434. PubMed ID: 38064905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Daudignon A; Quilichini B; Ameye G; Poirel H; Bastard C; Terré C
    Ann Biol Clin (Paris); 2016 Oct; 74(5):588-595. PubMed ID: 27707673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetics in the management of hematological malignancies: Guidelines from the Groupe Francophone de Cytogénétique Hématologique.
    Nguyen-Khac F; Bidet A; Chapiro E; Lefebvre C; Michaux L; Troadec MB
    Curr Res Transl Med; 2023; 71(4):103411. PubMed ID: 37984195
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytogenetics in the management of children and adult acute lymphoblastic leukemia (ALL): an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Baranger L; Cuccuini W; Lefebvre C; Luquet I; Perot C; Radford I; Lafage-Pochitaloff M
    Ann Biol Clin (Paris); 2016 Oct; 74(5):547-560. PubMed ID: 27707671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.
    Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
    Leukemia; 2019 Aug; 33(8):1851-1867. PubMed ID: 30696948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Bilhou-Nabéra C; Bidet A; Eclache V; Lippert E; Mozziconacci MJ
    Ann Biol Clin (Paris); 2016 Oct; 74(5):517-523. PubMed ID: 27477946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
    Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Nguyen-Khac F; Borie C; Callet-Bauchu E; Eclache V; Struski S
    Ann Biol Clin (Paris); 2016 Oct; 74(5):561-567. PubMed ID: 27628190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetics.
    Kearney L
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee.
    Larson DP; Akkari YM; Van Dyke DL; Raca G; Gardner JA; Rehder CW; Kaiser-Rogers KA; Eagle P; Yuhas JA; Gu J; Toydemir RM; Kearney H; Conlin LK; Tang G; Dolan MM; Ketterling RP; Peterson JF
    Arch Pathol Lab Med; 2021 Feb; 145(2):176-190. PubMed ID: 32886736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of a double agent: cytogenetics in hematology].
    Berger R
    Pathol Biol (Paris); 2003 Aug; 51(6):305-6. PubMed ID: 12927886
    [No Abstract]   [Full Text] [Related]  

  • 18. The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Nguyen-Khac F; Bidet A; Troadec MB; Veronese L; Auger N; Daudignon A; Nadal N; Penther D; Michaux L; Lafage-Pochitaloff M; Lefebvre C
    Leukemia; 2023 Apr; 37(4):946-947. PubMed ID: 36707618
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.
    Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
    Leukemia; 2023 May; 37(5):1170-1172. PubMed ID: 36973349
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
    Maciejewski JP; Tiu RV; O'Keefe C
    Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.